Get the Stockscreener App
1.77
1.14%
0.02
Pre-market:
1.70
-0.07
-3.95%
Sunshine Biopharma Inc stock is traded at $1.77, with a volume of 203.78K.
It is up +1.14% in the last 24 hours and up +18.79% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$1.75
Open:
$1.75
24h Volume:
203.78K
Relative Volume:
0.29
Market Cap:
$8.06M
Revenue:
$32.96M
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.0114
EPS:
-155.3294
Net Cash Flow:
$-14.00M
1W Performance:
-9.23%
1M Performance:
+18.79%
6M Performance:
+31.11%
1Y Performance:
-37.23%
1-Day Range:
$1.70
$1.79
1-Week Range:
$1.70
$2.13
52-Week Range:
$1.1693
$3.90
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.77 | 8.59M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
What risks investors should watch in Sunshine Biopharma Inc. Equity Warrant stockQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Will Sunshine Biopharma Inc. Equity Warrant stock deliver shareholder valueMarket Movers & AI Based Trade Execution Alerts - newser.com
How Sunshine Biopharma Inc. stock reacts to bond yieldsWeekly Trade Summary & Low Drawdown Investment Strategies - newser.com
Is Sunshine Biopharma Inc. stock a dividend growth opportunityEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Why analysts remain bullish on Sunshine Biopharma Inc. stockQuarterly Profit Review & Reliable Breakout Forecasts - newser.com
What institutional flow reveals about Sunshine Biopharma Inc. Equity WarrantGap Down & Weekly Return Optimization Plans - newser.com
Custom strategy builders for tracking Sunshine Biopharma Inc. Equity WarrantEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
How sentiment analysis helps forecast Sunshine Biopharma Inc. Equity WarrantJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com
How to monitor Sunshine Biopharma Inc. Equity Warrant with trend dashboardsJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Custom watchlist performance reports with Sunshine Biopharma Inc. Equity WarrantVolume Spike & Expert Curated Trade Setups - newser.com
What catalysts could drive Sunshine Biopharma Inc. Equity Warrant stock higherSell Signal & Low Drawdown Trading Techniques - newser.com
Is a relief rally coming for Sunshine Biopharma Inc. Equity Warrant holdersJuly 2025 Trends & Stock Portfolio Risk Management - newser.com
Published on: 2025-11-02 21:31:22 - newser.com
Is Sunshine Biopharma Inc. stock attractive after correctionQuarterly Earnings Summary & Precise Buy Zone Identification - newser.com
Should you wait for a breakout in Sunshine Biopharma Inc. Equity WarrantPortfolio Update Summary & Advanced Swing Trade Entry Plans - newser.com
Is Sunshine Biopharma Inc. stock attractive for passive investorsTrade Risk Report & Smart Swing Trading Techniques - newser.com
How Sunshine Biopharma Inc. Equity Warrant stock performs in weak economyEarnings Summary Report & Daily Momentum Trading Reports - newser.com
Will earnings trigger a reversal in Sunshine Biopharma Inc. Equity WarrantWeekly Gains Report & Accurate Intraday Trade Tips - newser.com
Will Sunshine Biopharma Inc. Equity Warrant stock go up soonEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Published on: 2025-11-02 03:31:24 - newser.com
Published on: 2025-11-02 02:41:28 - newser.com
Published on: 2025-11-02 02:34:14 - newser.com
Is Sunshine Biopharma Inc. stock attractive for long term wealth buildingJuly 2025 Outlook & AI Based Buy/Sell Signal Reports - newser.com
Using R and stats models for Sunshine Biopharma Inc. forecastingMarket Performance Summary & Growth Focused Entry Reports - newser.com
When is the best time to exit Sunshine Biopharma Inc. Equity WarrantJobs Report & Verified Chart Pattern Signals - newser.com
Published on: 2025-10-31 23:50:27 - newser.com
How Sunshine Biopharma Inc. stock responds to policy changesJuly 2025 PostEarnings & Verified Short-Term Plans - newser.com
Sunshine Biopharma Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Published on: 2025-10-31 06:01:30 - newser.com
Tick level data insight on Sunshine Biopharma Inc. volatilityOptions Play & Weekly Return Optimization Plans - newser.com
Published on: 2025-10-31 05:06:59 - newser.com
How resilient is Sunshine Biopharma Inc. stock in market downturnsJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
How Sunshine Biopharma Inc. stock benefits from tech adoptionJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
How Sunshine Biopharma Inc. Equity Warrant stock trades during market volatilityJuly 2025 Short Interest & Weekly Stock Performance Updates - newser.com
Analyzing Sunshine Biopharma Inc. Equity Warrant with risk reward ratio charts2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Published on: 2025-10-31 02:46:44 - newser.com
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):